1,301 results on '"Pascoal, Tharick A"'
Search Results
2. Neuropsychiatric Symptoms and Microglial Activation in Patients with Alzheimer Disease
3. Hormone therapy is associated with lower Alzheimer’s disease tau biomarkers in post-menopausal females -evidence from two independent cohorts
4. Tau follows principal axes of functional and structural brain organization in Alzheimer’s disease
5. The relation of synaptic biomarkers with Aβ, tau, glial activation, and neurodegeneration in Alzheimer’s disease
6. Alzheimer blood biomarkers: practical guidelines for study design, sample collection, processing, biobanking, measurement and result reporting
7. Comparison of immunoassay- with mass spectrometry-derived p-tau quantification for the detection of Alzheimer’s disease pathology
8. Biomarker-based staging of Alzheimer disease: rationale and clinical applications
9. The GABAergic system in Alzheimer’s disease: a systematic review with meta-analysis
10. APOEε4 potentiates amyloid β effects on longitudinal tau pathology
11. Modeling the progression of neuropsychiatric symptoms in Alzheimer’s disease with PET-based Braak staging
12. The neurophysiological brain-fingerprint of Parkinson’s disease
13. 14-3-3 ζ/δ-reported early synaptic injury in Alzheimer’s disease is independently mediated by sTREM2
14. Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease
15. Comparison of two plasma p-tau217 assays to detect and monitor Alzheimer’s pathology
16. Vascular risk burden is a key player in the early progression of Alzheimer’s disease
17. Cross-species comparative hippocampal transcriptomics in Alzheimer’s disease
18. Genetic risk for attention-deficit/hyperactivity disorder predicts cognitive decline and development of Alzheimer’s disease pathophysiology in cognitively unimpaired older adults
19. A multicenter comparison of [18F]flortaucipir, [18F]RO948, and [18F]MK6240 tau PET tracers to detect a common target ROI for differential diagnosis
20. A multicentre validation study of the diagnostic value of plasma neurofilament light.
21. Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease
22. Hippocampal GFAP-positive astrocyte responses to amyloid and tau pathologies
23. Impact of cardiometabolic factors and blood beta-amyloid on the volume of white matter hyperintensities in dementia-free subjects with cognitive complaints
24. Blood phospho-tau in Alzheimer disease: analysis, interpretation, and clinical utility
25. Biomarker modeling of Alzheimer’s disease using PET-based Braak staging
26. Staging of Alzheimer’s disease: past, present, and future perspectives
27. Association of locus coeruleus integrity with Braak stage and neuropsychiatric symptom severity in Alzheimer’s disease
28. Quantification of SNAP-25 with mass spectrometry and Simoa: a method comparison in Alzheimer’s disease
29. Author Correction: [11C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer’s disease
30. [11C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer’s disease
31. CSF tau368/total-tau ratio reflects cognitive performance and neocortical tau better compared to p-tau181 and p-tau217 in cognitively impaired individuals
32. Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum
33. Anosognosia predicts default mode network hypometabolism and clinical progression to dementia
34. CYP2C19 variant mitigates Alzheimer disease pathophysiology in vivo and postmortem
35. Reduction in Constitutively Activated Auditory Brainstem Microglia in Aging and Alzheimer’s Disease
36. Sex differences in Alzheimer's disease blood biomarkers in a Caribbean population of African ancestry: The Tobago Health Study
37. Effect of blood collection tube containing protease inhibitors on the pre-analytical stability of Alzheimer’s disease plasma biomarkers
38. Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology
39. Predicting functional decline in aging and Alzheimer’s disease with PET-based Braak staging
40. Microglial activation and tau propagate jointly across Braak stages
41. Amyloid-beta modulates the association between neurofilament light chain and brain atrophy in Alzheimer’s disease
42. APOEε4 potentiates the relationship between amyloid-β and tau pathologies
43. Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease
44. Plasma p-tau231: a new biomarker for incipient Alzheimer’s disease pathology
45. Association of plasma biomarkers of Alzheimer's disease and related disorders with cognition and cognitive decline: The MYHAT population‐based study.
46. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
47. Association Between β-Amyloid Accumulation and Incident Dementia in Individuals 80 Years or Older Without Dementia
48. The relation of synaptic biomarkers with Aβ, tau, glial activation, and neurodegeneration in Alzheimer’s disease.
49. Cholinergic dysfunction in the dorsal striatum promotes habit formation and maladaptive eating
50. Sex modulates the role of astrocyte reactivity in preclinical Alzheimer’s disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.